These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5374410)

  • 1. [Anemia in kidney diseases].
    Moiseeva OI; Iaroshevskiĭ AIa
    Ter Arkh; 1969 Jul; 41(7):44-51. PubMed ID: 5374410
    [No Abstract]   [Full Text] [Related]  

  • 2. [The plasmatic erythropoietic factor in anemia caused by chronic uremic nephropathies. (Apropos of 12 cases)].
    BOULET P; MIROUZE J; BARJON P
    J Urol Nephrol (Paris); 1961 Jun; 67():416-24. PubMed ID: 13871825
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anemia of chronic renal insufficiency].
    Danieli G; Montroni M
    G Clin Med; 1966 Nov; 47(11):1065-110. PubMed ID: 5999048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenetic factors in renal anemia].
    Blumberg A
    Dtsch Med Wochenschr; 1973 Feb; 98(5):217-8. PubMed ID: 4684530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interactions between bones, hematopoiesis and kidney with reference to the sex hormones. 1. Bones and hematopoiesis, hematopoiesis and kidney--effects of androgens, androgen deficiency and anemia or estrogen therapy and anemia].
    Schulz W
    Fortschr Med; 1978 Dec; 96(45):2273-6. PubMed ID: 720999
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nephrogenic anemia and hormones - the etiological mechanism of the disease].
    Maekawa T
    Horumon To Rinsho; 1974 Aug; 22(8):935-41. PubMed ID: 4476257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary edema in kidney diseases. Radiographic aspects and pathogenesis].
    Schermuly W; Nieth H; Biskamp K
    Z Klin Med; 1965 Sep; 158(6):461-500. PubMed ID: 5885705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acid-soluble srythrocytic nucleotides in anemia caused by chronic uremia].
    Comellini L; Mei V; Bonfiglioli G
    Clin Pediatr (Bologna); 1967 Dec; 49(12):721-32. PubMed ID: 5600004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior and significance of plasmatic erythropoietin in anemias in the course of chronic renal insufficiency].
    Gambaro GC; Fresco G; Aranzulla G; De Ferrari G; Gurreri G
    Arch Maragliano Patol Clin; 1970; 26(3):181-97. PubMed ID: 5538115
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia of chronic kidney disease: CHOIR and the FDA.
    Singh AK
    Nat Clin Pract Nephrol; 2007 Aug; 3(8):406-7. PubMed ID: 17593919
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin therapy: need for rationality and active surveillance.
    Cazzola M
    Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regression of uremia-induced suppression of erythropoiesis in patients with chronic kidney disease].
    Uhl N; Rehn K
    Verh Dtsch Ges Inn Med; 1974; 80():755-7. PubMed ID: 4454655
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anemia in kidney diseases].
    Popławski A
    Przegl Lek; 1995; 52(3):78-9. PubMed ID: 7644676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Renal anemia].
    Salmi HA
    Sotilaslaak Aikak; 1968; 43(1):9-18. PubMed ID: 5685747
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the pathogenesis of anemia in nephropathies].
    Pugliese F; Martinelli M
    Policlinico Med; 1969; 76(3):157-64. PubMed ID: 5803025
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nephrogenic anemia].
    SCHULLER A; YELAVIC D
    Arch Med Exp; 1960; 23():651-62. PubMed ID: 13748812
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for the evaluation of the severity of established renal disease. Council on the Kidney in Cardiovascular disease. American Heart Association, 1971.
    Ann Intern Med; 1971 Aug; 75(2):251-2. PubMed ID: 5558653
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anemia in kidney diseases].
    Karastanev I; Atanasov K
    Urol Nefrol (Mosk); 1974; (6):17-9. PubMed ID: 4446179
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis of neurologic disorders during kidney failure].
    Korchemnyĭ VA
    Vrach Delo; 1977 Feb; (2):81-4. PubMed ID: 860471
    [No Abstract]   [Full Text] [Related]  

  • 20. [CERA: Continuous Erythropoietin Receptor Activator for anemia in CKD patients].
    Cozzolino M
    G Ital Nefrol; 2009; 26(1):8. PubMed ID: 19255955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.